Literature DB >> 4092002

Amiodarone reduces plasma warfarin clearance in man.

A H Watt, M R Stephens, D C Buss, P A Routledge.   

Abstract

Amiodarone is an effective antiarrhythmic agent whose use is associated with several drug interactions one of which is potentiation of the action of warfarin. The mechanism of this interaction has hitherto been unclear. We examined possible mechanisms in eight patients. Total plasma warfarin clearance was found to be reduced by amiodarone. No change was detected in the binding of warfarin to plasma proteins. No relationship was found between plasma amiodarone concentrations and the change in warfarin clearance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4092002      PMCID: PMC1400826          DOI: 10.1111/j.1365-2125.1985.tb05135.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Drug interactions with amiodarone.

Authors:  F I Marcus
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

Review 2.  Drug interactions with warfarin.

Authors:  M J Serlin; A M Breckenridge
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

Review 3.  Amiodarone: the experience of the past decade.

Authors:  W J McKenna; E Rowland; D M Krikler
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

4.  Dangers of amiodarone and anticoagulant treatment.

Authors:  M J Serlin; R G Sibeon; G J Green
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-04

5.  Dangers of amiodarone and anticoagulant treatment.

Authors:  A Rees; J J Dalal; P G Reid; A H Henderson; M J Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30

6.  Influence of amiodarone on antipyrine pharmacokinetics in three patients with ventricular tachycardia.

Authors:  C Staiger; R Jauernig; J de Vries; E Weber
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

7.  The potentiation of warfarin anticoagulation by amiodarone.

Authors:  A Hamer; T Peter; W J Mandel; M M Scheinman; D Weiss
Journal:  Circulation       Date:  1982-05       Impact factor: 29.690

8.  Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.

Authors:  J J Heger; E N Prystowsky; D P Zipes
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

9.  Efficacy of amiodarone for refractory supraventricular tachyarrhythmias.

Authors:  T B Graboys; P J Podrid; B Lown
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

10.  High-pressure liquid chromatographic analysis of drugs in biological fluids I. Warfarin.

Authors:  T D Bjornsson; T F Blaschke; P J Meffin
Journal:  J Pharm Sci       Date:  1977-01       Impact factor: 3.534

  10 in total
  5 in total

1.  Investigation of patients with abnormal response to warfarin.

Authors:  D P Bentley; G Backhouse; A Hutchings; R L Haddon; B Spragg; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

Review 2.  Pharmacokinetic drug interactions with amiodarone.

Authors:  L J Lesko
Journal:  Clin Pharmacokinet       Date:  1989-08       Impact factor: 6.447

Review 3.  Clinically significant drug interactions with the oral anticoagulants.

Authors:  M D Freedman; A G Olatidoye
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

4.  The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose.

Authors:  Darja Herman; Igor Locatelli; Iztok Grabnar; Polona Peternel; Mojca Stegnar; Mitja Lainscak; Ales Mrhar; Katja Breskvar; Vita Dolzan
Journal:  Eur J Clin Pharmacol       Date:  2006-03-22       Impact factor: 2.953

5.  Amiodarone pharmacokinetics. I. Acute dose-dependent disposition studies in rats.

Authors:  S J Weir; C T Ueda
Journal:  J Pharmacokinet Biopharm       Date:  1986-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.